Oxalate Nephropathy After Kidney Transplantation: Risk Factors and Outcomes of Two Phenotypes
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15368 ↗At a glance
Journal article in Clinical Transplantation, 2024. Written by Neetika Garg and 9 co-authors. Institution: Division of Nephrology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA. Major MEDLINE topics: Kidney Transplantation, Graft Survival, Postoperative Complications, Phenotype. Cited 3 times so far (Crossref); 27 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: University of Wisconsin School of Medicine and Public Health Shapiro Summer Search Program.
Abstract (original language)
Describing risk factors and outcomes in kidney transplant recipients with oxalate nephropathy (ON) may help elucidate the pathogenesis and guide treatment strategies. We used a large single‐center database to identify patients with ON and categorized them into delayed graft function with ON (DGF‐ON) and late ON. Incidence density sampling was used to select controls. A total of 37 ON cases were diagnosed between 1/2011 and 1/2021. DGF‐ON ( n = 13) was diagnosed in 1.05% of the DGF population. Pancreatic atrophy on imaging (36.4% vs. 2.9%, p = 0.002) and gastric bypass history (7.7% vs. 0%; p = 0.06) were more common in DGF‐ON than with controls with DGF requiring biopsy but without evidence of ON. DGF‐ON was not associated with worse graft survival ( p = 0.98) or death‐censored graft survival ( p = 0.48). Late ON ( n = 24) was diagnosed after a mean of 78.2 months. Late ON patients were older (mean age 55.1 vs. 48.4 years; p = 0.02), more likely to be women (61.7% vs. 37.5%; p = 0.03), have gastric bypass history (8.3% vs. 0.8%; p = 0.02) and pancreatic atrophy on imaging (38.9% vs. 13.3%; p = 0.02). Late ON was associated with an increased risk of graft failure (HR 2.0; p = 0.07) and death‐censored graft loss (HR 2.5; p = 0.10). We describe two phenotypes of ON after kidney transplantation: DGF‐ON and late ON. Our study is the first to our knowledge to evaluate DGF‐ON with DGF controls without ON. Although limited by small sample size, DGF‐ON was not associated with adverse outcomes when compared with controls. Late ON predicted worse allograft outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Nephrology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Department of Population Health Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Department of Pathology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
ORCID profiles: Neetika Garg, Sandesh Parajuli, Fahad Aziz, Didier A Mandelbrot
Funding
- University of Wisconsin School of Medicine and Public Health Shapiro Summer Search Program
Cite
APA
Garg, N., Nguyen, T. T., Astor, B. C., Zhong, W., Parajuli, S., Aziz, F., Mohamed, M., Djamali, A., Norby, S. M., & Mandelbrot, D. A. (2024). Oxalate Nephropathy After Kidney Transplantation: Risk Factors and Outcomes of Two Phenotypes. Clinical Transplantation. https://doi.org/10.1111/ctr.15368
Vancouver
Garg N, Nguyen TT, Astor BC, Zhong W, Parajuli S, Aziz F, et al. Oxalate Nephropathy After Kidney Transplantation: Risk Factors and Outcomes of Two Phenotypes. Clinical Transplantation. 2024. doi:10.1111/ctr.15368
BibTeX
@article{Garg2024,
author = {Garg, Neetika and Nguyen, Thanh Thanh and Astor, Brad C and Zhong, Weixiong and Parajuli, Sandesh and Aziz, Fahad and Mohamed, Maha and Djamali, Arjang and Norby, Suzanne M and Mandelbrot, Didier A},
title = {Oxalate Nephropathy After Kidney Transplantation: Risk Factors and Outcomes of Two Phenotypes},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15368}
}
EUVIMED